Northwire Canada EditionThursday, July 23, 2026
Sign inSubscribe
Northwire
⌕
NIO 0.135 −3.6% III 7.22 −2.8% NCAU 0.295 −3.3% NEV 0.040 +0.0% ITR 3.00 −1.6% ALDE 2.79 −0.7% TECK 84.18 +4.4% FVI 11.83 −2.2% SUM 1.31 −1.5% RSMX 0.115 +4.5% STW 0.105 +5.0% PAT 0.250 +0.0% CCM 0.520 +0.0% SGN 0.255 +0.0% CNC 1.49 +1.4% PHNM 0.345 +6.2% NIO 0.135 −3.6% III 7.22 −2.8% NCAU 0.295 −3.3% NEV 0.040 +0.0% ITR 3.00 −1.6% ALDE 2.79 −0.7% TECK 84.18 +4.4% FVI 11.83 −2.2% SUM 1.31 −1.5% RSMX 0.115 +4.5% STW 0.105 +5.0% PAT 0.250 +0.0% CCM 0.520 +0.0% SGN 0.255 +0.0% CNC 1.49 +1.4% PHNM 0.345 +6.2%

Healthcare

Page 139
  1. Aug 04, 2025 · 16:30 · GUD

    Knight Therapeutics and Incyte Amend Supply and Distribution Agreement to Add Retifanlimab and Axatilimab in Latin America

    Knight Therapeutics and Incyte Amend Supply and Distribution Agreement to Add Retifanlimab and Axatilimab in Latin America

    01
  2. Aug 04, 2025 · 16:05 · ONCO

    Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement

    Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement

    02
  3. Aug 04, 2025 · 07:45 · GLAS

    Glass House Brands Provides Updates to Recent Events

    Glass House Brands Provides Updates to Recent Events

    03
  4. Aug 04, 2025 · 07:33 · QNTM

    Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

    Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

    04
  5. Aug 01, 2025 · 18:52 · SEGN

    Reem Capital, Kalron continue work on QT deal

    Reem Capital, Kalron continue work on QT deal

    05
  6. Aug 01, 2025 · 07:00 · MDNA

    Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights

    Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights

    06
  7. Aug 01, 2025 · 03:22 · HEM

    Hemostemix increases private placement to $3-million

    Hemostemix increases private placement to $3-million

    07
  8. Jul 31, 2025 · 21:05 · PTEC

    Principal Technologies closes $624k private placement

    Principal Technologies closes $624k private placement

    08
  9. Jul 31, 2025 · 20:52 · GUD

    Knight submits supplemental application for Minjuvi

    Knight submits supplemental application for Minjuvi

    09
  10. Jul 31, 2025 · 18:17 · AIDR

    Treatment.com talks up Rocket Doctor

    Treatment.com talks up Rocket Doctor

    10
  11. Jul 31, 2025 · 17:42 · BCT

    Briacell Therapeutics adds UCLA to breast cancer study

    Briacell Therapeutics adds UCLA to breast cancer study

    11
  12. Jul 31, 2025 · 17:35 · QNTM

    Quantum licensee begins $5-million (U.S.) raise

    Quantum licensee begins $5-million (U.S.) raise

    12
  13. Jul 31, 2025 · 17:29 · PTEC

    Principal Tech investor adds 2.08 million shares

    Principal Tech investor adds 2.08 million shares

    13
  14. Jul 31, 2025 · 17:09 · LSL

    LSL Pharma enters LOI to acquire Quebec competitor

    LSL Pharma enters LOI to acquire Quebec competitor

    14
← Newer Older →